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Introduction
Atherosclerosis is a chronic inflammatory disease of the arteries, characterised by the activation of endothelial cells to express inflammatory mediators and the subsequent recruitment of monocytes into the artery wall, which may differentiate to form fat-laden foam cells [1] . Among candidate inflammatory stimuli that may potentiate this condition, stimulation of Toll-like receptors (TLRs) has emerged as a key factor in atherogenesis [2] .
The ten human TLRs serve to initiate inflammatory signalling in response to the detection of conserved pathogen associated molecular patterns (PAMPs). TLR2, in conjunction with heterodimerisation partners TLR6 or TLR1, recognises di-acyl or triacyl bacterial lipopeptides (BLP), respectively. TLR3 recognises double stranded RNA, while TLRs 7 and 8 recognise single stranded RNA motifs, indicating a role for these receptors in anti-viral defence [3] . TLRs 4, 5 and 9 recognise bacterial lipopolysaccharide (LPS), flagellin and the unmethylated cytosine-phosphate-guanosine (CpG) DNA motif, respectively, while no ligand has yet been identified for TLR10. In each case, engagement of TLRs with their respective ligands leads to the induction of inflammatory signalling and the resultant expression of inflammatory mediators such as interleukin (IL)-8, tumour necrosis factor (TNF)-and E-selectin [4] .
Mice deficient in a shared signalling adaptor of the TLRs, myeloid differentiation factor-88 (MyD88), have been shown to be resistant to atherogenesis [5, 6] , while genetic deletion of TLR2 or TLR4 also leads to a reduction in aortic plaque burden of between 30% and 60% in mouse models of atherosclerosis [5] [6] [7] [8] . Accordingly, experimental 4 stimulation of TLR2 or TLR4 signalling via recurrent injection of either BLP or LPS markedly accelerates atherogenesis [8] [9] [10] . In human atheromatous tissue, expression of TLRs 2, 4 and 5 is markedly upregulated compared to healthy artery, and TLR2 and TLR4-expressing cells within plaque were shown to co-stain for activated nuclear factor (NF)-B [11] .
The likely stimulants of TLRs in the diseased artery wall remain to be clearly identified. However, as many previous studies have reported the presence of bacterial products within human atheroma [12] [13] [14] [15] , and seropositivity to common viruses has also been associated with atherosclerosis [16, 17] , it is likely that vascular cells may be exposed to diverse TLR ligands of both bacterial and viral origin during the development of atheroma.
As little information exists on the responsiveness of primary human vascular cells to PAMPs specific for each of the TLRs, and since arterial tissues are more susceptible to the development of atherosclerosis than venous tissues, we aimed to establish the range of TLR-ligands that may be capable of stimulating expression of IL-8 and E-selectin in primary venous and arterial endothelial and smooth muscle cells, and sought evidence for the presence of these PAMPs in human atheromatous tissue. Table 1 .
Materials and Methods

Culture of primary vascular cells
16S PCR identification of bacterial DNA in atheromatous tissue
Atheromatous plaques (n=3) were obtained from routine carotid endarterectomy, before lysis and DNA extraction using TRIzol reagent (Sigma). PCR was then performed using consensus primers 27f and 1387r that amplify the 16S rRNA gene of diverse bacteria, as described previously [19] . A positive control PCR containing 10 ng of E. coli genomic DNA was included in each experiment. PCR products were cloned using the TOPO TA Cloning Kit (Invitrogen), and selected clones were sequenced in one direction using the 357F primer to obtain a minimum of 500 bp of sequence from a variable region of the 16S rRNA gene. All clone sequences were then compared against the EMBL/GenBank sequence databases using the BLAST algorithm. Clones sharing 98%
identity with a known sequence were positively identified as belonging to that species.
Sequences with a lower percentage identity were analysed using the PHYLIP suite of programmes to determine the phylogenetic position of the clone. For all 16S-work, strict anti-contamination procedures were employed. Separate rooms were used for sample preparation, PCR reactions and analysis of reaction products. Filter tips were used at all 8 stages and for each set of samples being analysed and negative controls (sterile water)
were included. 
TLR-transfection assay
Results
Responsiveness of primary vascular cells to TLR ligands
Primary human vascular cells were exposed to PAMPs specific for each of the functional human TLRs at concentrations that were found to induce maximal induction of TNFsecretion in TLR-competent macrophages (Figure 1 ), or as described previously [21] .
Secretion of IL-8 and expresssion of E-selectin were measured as markers of cellular 9 inflammatory activation as these mediators have been implicated in the progression of atherosclerosis in previous studies [22, 23] . A significant increase in IL-8 secretion was 
Investigation of bacterial 16S DNA signatures in human carotid atheroma
In order to gain information on the potential prior exposure of atheromatous tissue to bacterial ligands of the TLRs, DNA was extracted from three atheromatous plaques and amplified by PCR using primers specific for the bacterial 16S DNA gene. 58 cloned PCR products were sequenced, of which 56 could be identified to bacterial genus or species level. The most frequently isolated clones corresponded to Acinetobacter species, followed by Brevundimonas species and Lysobacter enzymogenes. A further 14 bacterial genera were identified at lower frequencies ( Table 2) . No amplification product was detected in control experiments using identical reagents with sterile water replacing template DNA.
Biological activity of TLR2, TLR4 and TLR5 ligands in human atheroma
Given the likelihood that developing plaques are at some stage exposed to ligands of TLR2, TLR4 and TLR5, we next aimed to determine whether such PAMPs may remain detectable in human atheroma. To achieve this, endarterectomy samples were homogenised and applied to HEK-293 cells transfected with NF-B-sensitive reporter and TLR2, TLR4 or TLR5. P. gingivalis LPS, E. coli LPS and flagellin were detected only in cells expressing TLR2, TLR4 or TLR5, respectively, confirming the purity of these reagents and also the specificity of the TLR-reporter assay ( Figure 6A ). No stimulants of TLR4 or TLR5 could be detected in the atheroma samples, although in one plaque sample there was a significant increase in reporter activity in cells expressing TLR2, but not other TLRs, indicating the presence of a TLR2 ligand in this sample ( Figure 6B ).
Discussion
Since the observation that TLR-signalling is a key modulator of atherosclerosis in animal models [5] [6] [7] [8] [9] [10] Notably, the identification of responsiveness of arterial cells to flagellin appears to be novel, and adds weight to previous reports of TLR5 protein expression in internal mammary artery and intestinal microvessels [11, 24] . Uniquely among the vascular cell types examined, endothelial cells from the coronary artery also expressed TLR2 and were responsive to bacterial lipopeptide, in accordance with previous reports [25, 20] . The observation that arterial cells are responsive to a wider range of bacterial PAMPs than venous cells may be of relevance regarding the increased susceptibility of arteries to plaque formation compared to veins, as chronic bacterial infection has been reported to correlate with increased atherosclerosis risk [26, 27] , and immunohistochemical approaches have revealed the presence of diverse bacterial antigens in a high percentage of atheroma samples [13, [28] [29] [30] .
We next aimed to examine the possibility that atheromatous tissues may be exposed to the bacterial ligands of the receptors we identified to be functional in arterial tissues in this study, namely TLRs 2, 4, 5 and 9. Although extracts from atheromatous samples stimulated no TLR4-or TLR5-dependent signalling in the TLR-transfection assays, we cannot exclude the possibility that small numbers of bacteria expressing LPS or flagellin may nevertheless be present in the samples as the limit of sensitivity of the assay is around 10 3 bacterial cells per ml. It is more likely, however, that biologically active PAMPs delivered to the artery wall exert their atherogenic properties only transiently, being soon degraded and thereby losing their inflammatory potential, such as by proteolysis of flagellin or deacylation of LPS [31] . Indeed, an emerging consensus is that bacterial antigens and DNA, rather than live bacteria, accumulate within atheroma [12, 13, 32] .
Seeking alternative evidence of exposure of atheroma to bacterial PAMPs, we examined bacterial 16S DNA signatures from atheroma, as 16S gene containing DNA fragments have been shown to remain intact for years in tissues after degradation of other bacterial macromolecules [33] . Confirming the results of several recent studies, we found an abundant diversity of bacterial 16S DNA signatures in human atheroma, extending the list of species discovered in atheroma to include Acinetobacter and Brevundimonas species [14, 15, 30, [34] [35] [36] . Notably, all of the bacteria identified in this and previous studies are thought to express ligands of TLR2 and TLR9, while endotoxin of Acinetobacter species stimulates TLR4-signalling and approximately half of the genera identified in our study are thought to be motile and express flagellin ( Table 2 ). The 16S data therefore supports the notion that during the development of human atheroma, such tissues may be exposed, at least transiently, to ligands of TLR2, TLR4, TLR5 and TLR9.
In summary, we have shown that arterial cells are typically responsive to a wider range of PAMPs than venous cells and that it is likely that arterial cells may be exposed, at least transiently, to bacterial ligands of TLRs 2, 4, 5 and 9 during the development of carotid 13 atheroma. While the observations presented here do not allow any conclusion to be drawn as to whether or not bacteria potentiate atherosclerosis, it seems likely that if this is the case, no single organism or source of bacterial antigens is likely to be identified as a unique contributor to atherogenesis. DNA extracted from three atheromatous plaques obtained from routine carotid endarterectomy was amplified using broad-range 16S gene specific primers. 58 cloned 25 products were sequenced, of which 56 could be identified by BLAST searches with >97% identity to established bacterial species or genera. Listed also is an indication of whether these organisms are thought to be motile or otherwise. 
